Your browser doesn't support javascript.
loading
Adaptive transcriptomic and immune infiltrate responses in the tumor immune microenvironment following neoadjuvant chemotherapy in high grade serous ovarian cancer reveal novel prognostic associations and activation of pro-tumorigenic pathways.
James, Nicole E; Woodman, Morgan; De La Cruz, Payton; Eurich, Katrin; Ozsoy, Melih Arda; Schorl, Christoph; Hanley, Linda C; Ribeiro, Jennifer R.
Afiliación
  • James NE; Department of Obstetrics and Gynecology, Program in Women's Oncology, Women and Infants Hospital, Providence, RI, United States.
  • Woodman M; Department of Obstetrics and Gynecology, Warren-Alpert Medical School of Brown University, Providence, RI, United States.
  • De La Cruz P; Department of Obstetrics and Gynecology, Program in Women's Oncology, Women and Infants Hospital, Providence, RI, United States.
  • Eurich K; Pathobiology Graduate Program, Brown University, Providence, RI, United States.
  • Ozsoy MA; Department of Obstetrics and Gynecology, Program in Women's Oncology, Women and Infants Hospital, Providence, RI, United States.
  • Schorl C; Department of Obstetrics and Gynecology, Warren-Alpert Medical School of Brown University, Providence, RI, United States.
  • Hanley LC; Department of Biochemistry, Brown University, Providence, RI, United States.
  • Ribeiro JR; Department of Molecular Biology, Cell Biology, and Biochemistry, Brown University, Providence, RI, United States.
Front Immunol ; 13: 965331, 2022.
Article en En | MEDLINE | ID: mdl-36131935
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Antineoplásicos Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Antineoplásicos Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article